Royal Philips PHG
$28.61 −$0.64 (-2.19%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $28.61 0.00%
Open$28.89
Prev close$29.25
Day range$28.56 – $29.14
Volume2.42M
Market cap$27.97B
P/E (TTM)26.3
Dividend yield3.44%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026 · reported in EUR
Revenue€4.39B+2.1% YoY
Operating profit€165.00M-50.0% YoY
Net profit€28.00M-85.0% YoY
Diluted EPS€0.03-84.2% YoY
Free cash flow€382.00M+126.0% YoY
Operating cash flow€544.00M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin46.4%
Operating margin8.9%
Net margin5.4%
Return on equity8.6%
Return on assets3.5%
Return on invested capital5.7%
Current ratio1.33
Liabilities / assets58.6%
Cash & investments€2.75B
Total debt€8.14B
Net cash (debt)-€5.39B
Free cash flow / sales10.3%
Where the revenue comes from
Quarter 2026/Q3
By business line
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
Income statement
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Revenue as Reported | €4.39B | €4.36B | €3.91B | €17.83B | €5.10B |
| Total Operating Revenue | €4.39B | €4.36B | €3.91B | €17.83B | €5.10B |
| Cost of Revenue | €2.35B | €2.21B | €2.14B | €9.78B | €2.81B |
| Gross Profit | €2.04B | €2.15B | €1.77B | €8.06B | €2.29B |
| Operating Expense | €1.88B | €1.54B | €1.52B | €6.61B | €1.72B |
| Selling and Admin Expenses | €1.17B | €1.21B | €1.18B | €4.97B | €1.31B |
| -Selling & Marketing Expense | €1.02B | €1.05B | €1.01B | €4.34B | €1.15B |
| -General & Admin Expense | €158.00M | €154.00M | €177.00M | €628.00M | €158.00M |
| Research & Development | €410.00M | €484.00M | €394.00M | €1.70B | €427.00M |
| Other Operating Expenses | €291.00M | -€151.00M | -€54.00M | -€61.00M | -€9.00M |
| Operating Profit | €165.00M | €610.00M | €242.00M | €1.45B | €565.00M |
| Net Non-Operating Interest Income (Expense) | -€42.00M | -€62.00M | -€48.00M | -€216.00M | -€53.00M |
| Non-Operating Interest Income | €42.00M | €33.00M | €35.00M | €83.00M | €8.00M |
| Non-Operating Interest Expense | €84.00M | €95.00M | €83.00M | €294.00M | €56.00M |
| Other Income (Expense) | -€1.00M | -€1.00M | -€4.00M | -€50.00M | -€44.00M |
| Earnings from Equity Interest | -€1.00M | -€1.00M | -€4.00M | -€9.00M | -€3.00M |
| Pretax Profit | €122.00M | €546.00M | €190.00M | €1.18B | €466.00M |
| Tax | €92.00M | €160.00M | €44.00M | €282.00M | €74.00M |
| Net Profit | €28.00M | €386.00M | €146.00M | €897.00M | €398.00M |
| Profit from Continuing Operations | €30.00M | €386.00M | €146.00M | €901.00M | €393.00M |
| Net Income from Discontinuous Operations | -€2.00M | €0.00 | €0.00 | -€4.00M | €4.00M |
| Minority Interests | €1.00M | €2.00M | -€5.00M | €1.00M | €2.00M |
| Net Income to Parent Company | €27.00M | €384.00M | €151.00M | €895.00M | €395.00M |
| Net Income to Common Stockholders | €27.00M | €384.00M | €151.00M | €895.00M | €395.00M |
| Basic EPS | €0.03 | €0.40 | €0.16 | €0.94 | €0.42 |
| Diluted EPS | €0.03 | €0.40 | €0.16 | €0.93 | €0.42 |
| Dividend Per Share | €0.00 | €0.87 | €0.00 | €0.85 | €0.00 |
| Total Other Finance Costs | – | – | – | €5.00M | – |
| Gain on Sale of Security | – | – | – | -€17.00M | – |
| Special Income (Charges) | – | – | – | -€24.00M | – |
| -Less:Impairment of Capital Assets | – | – | – | €0.00 | – |
| -Gain on Sale Of Business | – | – | – | -€25.00M | – |
| -Gain on Sale of Property/Plant/Equipment | – | – | – | €1.00M | – |
Balance sheet
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €28.03B | €26.70B | €27.27B | €26.94B | €26.94B |
| Total Current Assets | €10.51B | €9.33B | €9.78B | €9.93B | €9.93B |
| Cash and Cash Equivalents & Short-Term Investments | €2.75B | €1.79B | €2.59B | €2.79B | €2.79B |
| -Cash and Cash Equivalents | €2.75B | €1.79B | €2.59B | €2.79B | €2.79B |
| Receivables | €3.62B | €3.60B | €3.31B | €3.95B | €3.95B |
| -Accounts Receivable | €3.57B | €3.55B | €3.26B | €3.34B | €3.34B |
| -Taxes Receivable | €49.00M | €47.00M | €45.00M | €60.00M | €60.00M |
| Inventory | €3.40B | €3.22B | €3.11B | €2.87B | €2.87B |
| Other Current Assets | €686.00M | €665.00M | €628.00M | -€5.00M | -€5.00M |
| Total Non-Current Assets | €17.52B | €17.37B | €17.48B | €17.01B | €17.01B |
| Net PPE | €2.20B | €2.17B | €2.18B | €2.22B | €2.22B |
| Investments and Advances | €876.00M | €862.00M | €850.00M | €852.00M | €852.00M |
| -Long Term Equity Investment | €153.00M | €151.00M | €142.00M | €148.00M | €148.00M |
| Non Current Accounts Receivables | €211.00M | €202.00M | €220.00M | €210.00M | €210.00M |
| Goodwill and Other Intangible Assets | €12.28B | €12.24B | €12.30B | €11.84B | €11.84B |
| -Goodwill | €9.74B | €9.68B | €9.61B | €9.27B | €9.27B |
| -Other Intangible Assets | €2.54B | €2.56B | €2.69B | €2.57B | €2.57B |
| Non-Current Deferred Assets | €1.83B | €1.77B | €1.81B | €1.77B | €1.77B |
| Other Non-Current Assets | €121.00M | €128.00M | €121.00M | €119.00M | €119.00M |
| Total Liabilities | €16.42B | €15.23B | €15.85B | €15.96B | €15.96B |
| Total Current Liabilities | €7.91B | €7.42B | €7.43B | €7.51B | €7.51B |
| Payables | €2.39B | €2.29B | €2.19B | €2.25B | €2.25B |
| -Accounts Payable | €2.14B | €2.08B | €1.99B | €1.93B | €1.93B |
| -Total Tax Payable | €258.00M | €168.00M | €198.00M | €307.00M | €307.00M |
| Current Accrued Expenses | €1.50B | €1.44B | €1.33B | €1.74B | €1.74B |
| Short-Term Debt and Capital Lease Obligation | €1.15B | €1.15B | €1.21B | €1.00B | €1.00B |
| -Current Debt | €1.15B | €1.15B | €1.21B | €793.00M | €793.00M |
| Current Provisions | €815.00M | €553.00M | €602.00M | €712.00M | €712.00M |
| Current Deferred Liabilities | €1.64B | €1.58B | €1.62B | €1.49B | €1.49B |
| Other Current Liabilities | €415.00M | €409.00M | €494.00M | €321.00M | €321.00M |
| Total Non-Current Liabilities | €8.51B | €7.80B | €8.42B | €8.44B | €8.44B |
| Long Term Debt and Capital Lease Obligation | €6.99B | €6.32B | €6.89B | €6.81B | €6.81B |
| -Long Term Debt | €6.99B | €6.32B | €6.89B | €6.05B | €6.05B |
| Non-Current Liabilities | €877.00M | €865.00M | €879.00M | €915.00M | €915.00M |
| Non-Current Deferred Liabilities | €564.00M | €541.00M | €529.00M | €551.00M | €551.00M |
| Other Non-Current Liabilities | €84.00M | €80.00M | €117.00M | €44.00M | €44.00M |
| Total Equity | €11.61B | €11.48B | €11.42B | €10.99B | €10.99B |
| Stockholders' Equity | €11.58B | €11.45B | €11.39B | €10.96B | €10.96B |
| Capital Stock | €197.00M | €197.00M | €193.00M | €193.00M | €193.00M |
| -Common Stock | €197.00M | €197.00M | €193.00M | €193.00M | €193.00M |
| Additional Paid-In Capital | €7.67B | €7.67B | €7.21B | €7.21B | €7.21B |
| Retained Earnings | €3.21B | €3.18B | €3.71B | €3.58B | €3.58B |
| Less: Treasury Stock | -€110.00M | -€113.00M | -€265.00M | -€298.00M | -€298.00M |
| Gains/Losses Not Affecting Retained Earnings | €707.00M | €644.00M | €527.00M | €291.00M | €291.00M |
| Other Equity Interests | -€91.00M | -€130.00M | €12.00M | -€16.00M | -€16.00M |
| Minority Interests | €29.00M | €29.00M | €26.00M | €32.00M | €32.00M |
| -Dividends Payable | – | €37.00M | – | – | – |
| -Due from Related Parties Current | – | – | – | €19.00M | €19.00M |
| -Other Receivables | – | – | – | €527.00M | €527.00M |
| Prepaid Assets | – | – | – | €180.00M | €180.00M |
| -Gross PPE | – | – | – | €5.92B | €5.92B |
| -Accumulated Depreciation | – | – | – | -€3.71B | -€3.71B |
| -Available for Sale Securities | – | – | – | €324.00M | €324.00M |
| -Other Payable | – | – | – | €17.00M | €17.00M |
| -Current Capital Lease Obligation | – | – | – | €207.00M | €207.00M |
| -Long Term Capital Lease Obligation | – | – | – | €757.00M | €757.00M |
| Derivative Product Liabilities | – | – | – | €123.00M | €123.00M |
Cash flow
| Line item | 2026 Q3 (EUR) |
2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €544.00M | €376.00M | €188.00M | €1.17B | €1.39B |
| Net cash flow from continuing operations | €544.00M | €377.00M | €190.00M | €1.17B | €1.39B |
| Net Income from Continuing Operations | €30.00M | €386.00M | €146.00M | €901.00M | €394.00M |
| Gain/Loss from Continuing Operations | €2.00M | -€98.00M | €17.00M | €32.00M | €27.00M |
| Depreciation & Depletion & Amortization | €254.00M | €381.00M | €265.00M | €1.12B | €278.00M |
| Deferred Tax | €92.00M | €160.00M | €44.00M | €282.00M | €74.00M |
| Other Non-Cash Items | €11.00M | €23.00M | €8.00M | €294.00M | €73.00M |
| Change in Working Capital | €220.00M | -€329.00M | -€263.00M | -€1.23B | €581.00M |
| -Change in Receivables | -€10.00M | -€301.00M | €219.00M | -€53.00M | -€175.00M |
| -Change in Inventory | -€201.00M | -€113.00M | -€226.00M | -€115.00M | €355.00M |
| -Change in Payables and Accrued Expense | €148.00M | €136.00M | -€115.00M | €97.00M | €360.00M |
| -Change in Other Current Liabilities | €22.00M | €19.00M | €18.00M | €54.00M | €50.00M |
| -Change In Other Working Capital | €261.00M | -€70.00M | -€159.00M | -€1.22B | -€9.00M |
| Net cash flow from investing | -€150.00M | -€19.00M | -€406.00M | -€737.00M | -€196.00M |
| Net Cash Flow from Continuing Investing Activities | -€150.00M | -€20.00M | -€406.00M | -€736.00M | -€196.00M |
| Capital Expenditure | -€136.00M | -€130.00M | -€136.00M | -€532.00M | -€148.00M |
| Net PPE Purchase and Sale | €2.00M | €3.00M | €3.00M | €9.00M | €2.00M |
| Net Intangibles Purchase and Sale | -€26.00M | -€27.00M | -€27.00M | -€136.00M | -€44.00M |
| Net Business Purchase and Sale | -€6.00M | €121.00M | -€221.00M | -€25.00M | -€18.00M |
| Net Investment Purchase and Sale | €16.00M | €13.00M | -€25.00M | -€52.00M | €12.00M |
| Financing Cash Flow | €566.00M | -€1.15B | -€23.00M | €107.00M | -€322.00M |
| Net Cash Flow from Continuing Financing Activities | €566.00M | -€1.15B | -€23.00M | €107.00M | -€322.00M |
| Net Issuance Payments Of Debt | €603.00M | -€767.00M | -€34.00M | €424.00M | -€327.00M |
| Net Common Stock Issuance | €1.00M | -€65.00M | €12.00M | €13.00M | €5.00M |
| Cash Dividends Paid | -€37.00M | -€321.00M | – | -€328.00M | €0.00 |
| Net Other Financing Charges | -€1.00M | -€1.00M | -€1.00M | -€2.00M | €0.00 |
| Ending Cash Balance | €2.75B | €1.79B | €2.59B | €2.79B | €2.79B |
| Net Change in Cash | €959.00M | -€797.00M | -€241.00M | €532.00M | €872.00M |
| Beginning Cash Balance | €1.79B | €2.59B | €2.79B | €2.40B | €1.91B |
| Effect of Exchange Rate Changes | €3.00M | -€6.00M | €39.00M | -€139.00M | €10.00M |
| Free Cash Flow | €382.00M | €219.00M | €25.00M | €504.00M | €1.20B |
| Net Other Investing Changes | – | €1.00M | – | -€1.00M | €0.00 |
No comments yet — be the first to weigh in on PHG.
Sign in to join the discussion.